Fundz

Averto Medical raised $30.5M in a series A financing led by Cormorant Asset Management to advance ColoSeal™ Intraluminal Diversion System for clinical testing and regulatory approvals.

PRIVATEMay 07, 2024

Amount Raised

$30.5 Million

Round Type

Series A

San FranciscoBiotechnologyHealth CareMedical

Investors

CvfLife Sci Venture PartnersVenrock Healthcare Capital PartnersCormorant Asset Management

Description

Averto Medical closed an oversubscribed $30.5 million series A financing led by Cormorant Asset Management with participation from Venrock Healthcare Capital Partners, LifeSci Venture Partners, CVF, and other investors. The funding will support advancing Averto Medical's clinical testing of the ColoSeal™ Intraluminal Diversion System towards regulatory approvals, targeting a multi-billion dollar market opportunity.

Quick answer

Averto Medical raised $30.5 Million in a Series A round, dated May 7, 2024. Investors: Cvf, Life Sci Venture Partners, Venrock Healthcare Capital Partners and Cormorant Asset Management. Averto Medical is based in San Francisco, California, United States.

How much did Averto Medical raise?
Averto Medical raised $30.5 Million in a Series A round on May 7, 2024.
Who invested in Averto Medical?
Cvf, Life Sci Venture Partners, Venrock Healthcare Capital Partners and Cormorant Asset Management are named as investors in this round.
What does Averto Medical do?
Averto Medical is a privately held clinical stage medical technology company focused on solutions for patients suffering from gastrointestinal diseases
Where is Averto Medical based and how big is it?
Averto Medical is based in San Francisco, California, United States. Fundz records about 8 employees.
Who are the decision-makers at Averto Medical?
Fundz holds 2 contacts at Averto Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Averto Medical that raised within 45 days of this round, from Fundz verified event records.

  • Prenuvo raised $85M on June 20, 2024.
  • Quantum Innovations raised $10M (Funding Round) on June 20, 2024.
  • Ronovo Surgical raised $44M (Series B) on June 20, 2024.
  • Insightec raised $150M (Funding Round) on June 18, 2024.
  • Maximum Fidelity Surgical Simulations raised $2.2M (Seed) on June 17, 2024.
  • Insightec raised $150M on June 17, 2024.

Who to call at Averto Medical, and when

A new round usually means Averto Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Averto Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Averto Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Averto Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Averto Medical

Location

San Francisco, California, United States

About

Averto Medical is a privately held clinical stage medical technology company focused on solutions for patients suffering from gastrointestinal diseases

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Averto Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Averto Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Averto Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.